
Sign up to save your podcasts
Or


In this episode, we examine whether first-trimester exposure to the antipsychotic olanzapine increases the risk of major fetal malformations. Does stopping medication abruptly also carry risks?
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.
 By Psychopharmacology Institute
By Psychopharmacology Institute4.6
268268 ratings
In this episode, we examine whether first-trimester exposure to the antipsychotic olanzapine increases the risk of major fetal malformations. Does stopping medication abruptly also carry risks?
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

75 Listeners

150 Listeners

262 Listeners

3,342 Listeners

159 Listeners

564 Listeners

1,346 Listeners

715 Listeners

239 Listeners

566 Listeners

17 Listeners

472 Listeners

725 Listeners

185 Listeners

139 Listeners